Logo
x

Search category

Subscribe Now

All Posts by Date

Samsung Bioepis Reports Results SB5 (biosimilar, adalimumab) in Two Studies for the Treatment of Behçet’s Syndrome-Related Uveitis and IBD

Samsung Bioepis Reports Results SB5 (biosimilar, adalimumab) in Two Studies for the Treatment of Behçet’s Syndrome-Related Uveitis...

Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.